Cargando…
Cognitive Deficits in Schizophrenia and Other Neuropsychiatric Disorders: Convergence of Preclinical and Clinical Evidence
Autores principales: | Stuchlik, Ales, Sumiyoshi, Tomiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275052/ https://www.ncbi.nlm.nih.gov/pubmed/25566009 http://dx.doi.org/10.3389/fnbeh.2014.00444 |
Ejemplares similares
-
Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia
por: Sumiyoshi, Tomiki, et al.
Publicado: (2013) -
Preclinical Evidence for the Mechanisms of Transcranial Direct Current Stimulation in the Treatment of Psychiatric Disorders; A Systematic Review
por: Yamada, Yuji, et al.
Publicado: (2021) -
Tandospirone, a 5-HT(1A) partial agonist, ameliorates aberrant lactate production in the prefrontal cortex of rats exposed to blockade of N-methy-D-aspartate receptors; Toward the therapeutics of cognitive impairment of schizophrenia
por: Uehara, Takashi, et al.
Publicado: (2014) -
Neural Correlates for Intrinsic Motivational Deficits of Schizophrenia; Implications for Therapeutics of Cognitive Impairment
por: Takeda, Kazuyoshi, et al.
Publicado: (2018) -
Electrophysiological and Neuropsychological Predictors of Conversion to Schizophrenia in At-Risk Subjects
por: Sumiyoshi, Tomiki, et al.
Publicado: (2013)